학술논문

Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration.
Document Type
Article
Source
Vaccines; May2022, Vol. 10 Issue 5, p690-690, 13p
Subject
COVID-19 vaccines
BOOSTER vaccines
VACCINATION
SARS-CoV-2
SARS-CoV-2 Omicron variant
Language
ISSN
2076393X
Abstract
Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)